Understanding how bone cells respond to osteoporosis treatments
Official title: The role of the osteocyte in responses to osteoporosis anabolic treatment in humans and mice
Funded at Massachusetts General Hospital · NIH-11085960 · Data updated 2026-11-12
This study is looking at how bone cells called osteocytes react to treatments for osteoporosis in post-menopausal women, with the hope of finding better ways to strengthen bones and improve current therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $433,997 |
| NIH project number | 5P50AR080596-03 |
| Project ID | NIH-11085960 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are post-menopausal women diagnosed with osteoporosis.
✕Less likely to help
Patients with osteoporosis who are not post-menopausal or those with other underlying bone disorders may not benefit from this research.
What this research studies
This research investigates the role of osteocytes, the primary cells in bone, in how they respond to anabolic treatments for osteoporosis. By examining human biopsy samples from post-menopausal women with osteoporosis and conducting experiments in mice, the study aims to uncover the mechanisms behind the effectiveness and limitations of current osteoporosis therapies. The goal is to identify new therapeutic targets that could lead to improved treatments for bone fragility. The research will compare the responses of osteocytes at different time points to better understand their role in treatment efficacy.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for osteoporosis, reducing fracture risk and improving bone health.
How similar studies have gone: Previous research has shown that understanding cellular responses in bone can lead to significant advancements in osteoporosis treatment, indicating that this approach has potential for success.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Baron, Roland E — Massachusetts General Hospital
- Study coordinator: Baron, Roland E
Related research
Other NIH-funded projects on the same topics.
-
Or olive-oil derived compound to prevent bone loss in women
A safe, orally taken nutraceutical may help prevent osteoporosis in adult women by supporting bone formation and reducing bone loss.
-
When to stop, switch, or pause long-term osteoporosis medicines for older adults
This project looks at whether stopping, switching, or taking breaks from long-term osteoporosis drugs changes fracture risk and side effects for older adults.
-
Cortical Bone Mechanics Technology to better screen for osteoporosis
A new noninvasive test called CBMT uses ulnar flexural rigidity to predict fracture risk better than standard bone density tests, helping adults who may be at risk for osteoporosis.
-
Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women
A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.
-
Metabolomics clues to osteoporosis risk in diverse populations
A study using small molecules in blood samples to understand osteoporosis risk, with a focus on aging, ethnicity, and sex differences.
-
Single-Cell Study of Bone Cells to Understand Osteoporosis
Researchers will study individual bone-related cells from people to uncover why aging leads to weaker bones and higher fracture risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.